Scribd
Upload
166 views2 pages

Biz Comm-Article Memo

The document discusses the potential benefits of public-private partnerships (PPPs) in healthcare and research & development in India. It notes that the Indian health minister emphasized PPPs can help private companies contribute to public health goals while being profitable. PPPs are meant to augment public systems, not replace government resources or policy. India's prime minister also urged setting up publicly-owned, privately-operated R&D facilities. Challenges include ensuring mutual cooperation between public and private sectors, while benefits include reducing drug costs and substituting imports through harmonious PPPs.

Uploaded by

MeghaDivakar
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOC, PDF, TXT or read online on Scribd
166 views2 pages

Biz Comm-Article Memo

The document discusses the potential benefits of public-private partnerships (PPPs) in healthcare and research & development in India. It notes that the Indian health minister emphasized PPPs can help private companies contribute to public health goals while being profitable. PPPs are meant to augment public systems, not replace government resources or policy. India's prime minister also urged setting up publicly-owned, privately-operated R&D facilities. Challenges include ensuring mutual cooperation between public and private sectors, while benefits include reducing drug costs and substituting imports through harmonious PPPs.

Uploaded by

MeghaDivakar
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOC, PDF, TXT or read online on Scribd
You are on page 1/ 2

Memo on BioSpectrum Article

To: Professor From: Student Date: 29th August, 2011 Subject: A Push for Affordable Healthcare. Power of Public Private Partnership (PPP) At 7th India Health Summit 2010 in New Delhi, Mr. Ghulam Nabi, the Union Minister for Health & Family Welfare, Government of India, stated the need to look t Public-Private Partnership as a synergic effect ensures the private also contribute to public health goals. Minister notes that there should be fine blend of Profitability & Corporate Responsibility. PPP is as a tool for augmenting the public health system but partnership is not meant to be substitution for lesser provisioning of government resources nor abdication of government policy. In return there is a urge to have sustainable & affordable healthcare. Indias prime minister urged setting up of publicly owned & privately operated worldclass R&D facilities. In support to R&D innovation the Department of Biotechnology along with Government of India has launched various initiatives leading to tremendous opportunities. Few major research centers & Indian biotechnology initiatives have commenced seed fund & promote flow of knowledge from national laboratories to the industries. PPP not a choice but a requirement as it calls for; 1. Sharing of ideas 2. Facilitating Technology Transfer & technical expertise 3. Provide environment to flourish R&D Hurdles for PPP: Synergic benefit can be fruitful by mutual co-operation of both the sectors. Pros of PPP: PPPs have the potential to nurture and catalyze R&D. Harmonious PPPs have cut costs of drugs & substituted imports.

Source: BioSpectrum- Jan 2011 Issue #1.

Memo on BioSpectrum Article


To: Professor From: Student Date: 29th August, 2011 Subject: India- Biotech hit $ 10 Billion by 2015. BioSpectrum organized the Biotech CEO Summit. First ever platform in India that brought together Biotech Stakeholders from various domains with a clear agenda of analyzing ways and means of achieving a target of $ billion by the end of 2010. Key to achieve agenda- Target of achieving $5 billion biotech industry by 2010, is realistic if initiative by government at policy level and ministrys willingness to take the progress forward is in ensured. Dr Kiran Mazumdar-Shaw, a prominent person in Indian biotech industry agrees on subject line. Many big pharma players are already developing strategic alliances & collaborative research programs with Indian partners and this trend is set to continue. Performance of Biotech industry in 2009-2010: 12% growth in Biopharma 37% growth in Bioagri 28% growth in Bioservices 18% growth in Bioindustrial sector BioSpectrum Analysis SWOT of Indian Biopharma and Bioservices sector (refer Article).
Source: BioSpectrum- March 2011 Issue #3.

You might also like